Hospira Recalls Injectables Due to Particulate Matter

Hospira’s Lake Forest, Ill., plant is voluntarily recalling one lot of 8.4 percent sodium bicarbonate injectable due to particulate matter in the single-dose glass fliptop vial.

The lot was distributed nationwide to wholesalers and hospitals in December.  The issue was identified via a complaint; no adverse events have been reported, Hospira said. The Pfizer unit added that it is conducting an investigation to determine root cause.

Hospira has been plagued with recalls over the last year due to particulate contamination.